In humans, CCK dose-dependently presents early satiety and reduces the energy intake at a buffet style meal, which was attenuated by the CCK-1 antagonist, loxiglumide (107)
Administered with fasted timing, circadian awareness, and oxidative demand alignment, they demonstrate why mechanistically informed combination therapy outperforms single-agent escalation every time
Misuse may cause permanent growth of internal organs
However, weight loss itselfa primary outcome of GLP-1 treatmentoften improves reflux symptoms
The findings suggest the potential for GLP-1 receptor agonists to influence hair loss positively, presenting a new treatment strategy for patients dealing with both insulin resistance and hair loss conditions
Menni C, Hernandez MM, Vital M, Mohney RP, Spector TD, Valdes AM (2019) Circulating levels of the anti-oxidant indoleproprionic acid are associated with higher gut microbiome diversity